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Abstract: 
CONTEXT 
In time, microbicides may provide women with dual prevention against pregnancy and STDs. 
Although several microbicide dimensions have been evaluated, little is known about women's 
preferences for contraceptive microbicides and correlates of these preferences. 
METHODS 
Acceptability of a hypothetical contraceptive microbicide cream or jelly was examined among a 
clinic-based sample of 266 women in Indianapolis from 2004 (when participants were aged 14–
22) to 2008. Group conjoint analyses and individual conjoint analyses were used to compare 
preferences with respect to four microbicide dimensions: contraceptive ability, efficacy in 
relation to condoms, timing of use and texture. Pearson's product moment correlations were used 
to examine the relationship between preferences for a contraceptive microbicide and selected 
characteristics of the women. 
RESULTS 
Overall, the top-rated microbicide dimensions were efficacy in relation to that of condoms and 
contraceptive ability (importance scores, 40.0 and 35.4 out of 100.0, respectively). When all 
dimension levels were compared, contraceptive ability was the most strongly preferred (part-
worth utility score, 8.9), and lower efficacy than that of condoms was the least strongly preferred 
(−11.9). Preference for contraceptive microbicides was positively associated with current 
contraceptive use, sexual agency, partner communication, commitment to avoiding pregnancy 
and perceived partner agreement about avoiding pregnancy (coefficients, 0.07–0.18). It was 
negatively associated with current or past nonuse of contraceptives, seeking pregnancy and 
perceived partner agreement about seeking pregnancy (−0.08 to −0.14). 
CONCLUSIONS 
Microbicides with dual prevention properties may be attractive to young women. Microbicide 
development and subsequent clinical trials should incorporate contraceptive microbicides. 
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Article: 
The sexual and reproductive health of adolescents and young adults continues to be a significant 
public health issue. In the United States, nearly one out of three females will become pregnant by 
age 20.[1] Overall, 49% of pregnancies in the United States are unintended,[2] and 51% of the 
two million publicly funded births in 2006 resulted from unintended pregnancies.[3] Unintended 
pregnancies led to approximately $11.1 billion in direct medical costs in 2006.[3] Furthermore, 
unintended pregnancies are not the only potential negative outcome of vaginal intercourse. Every 
year, approximately 19 million new cases of STDs are reported, resulting in an estimated $15.9 
billion in annual health care costs.[4] Among individuals aged 15–24, women are 
disproportionately burdened by both STDs and the long-term health consequences of 
infection.[4] 
Interest has been increasing in developing female--initiated technologies as a way to address 
some of the potential medical and psychosocial costs associated with adolescent sexual behavior. 
Past research highlights the worldwide need for and the feasibility of developing dual method 
technologies: products that could offer protection from STDs and unintended pregnancy.[5, 
6] Vaginal microbicides represent one such potential product category.[7] To date, vaginal 
microbicide development has focused on STD prevention—primarily, the prevention of HIV 
transmission during sex—and a clinical trial conducted from 2007 to 2010 offered promising 
results.[8, 9] In a randomized, placebo-controlled study among South African women 
(CAPRISA 004), a pericoital, tenofovir-based microbicide gel reduced HIV infection by an 
estimated 39% overall and by 54% in women with the highest rates of adherence to the 
microbicide regimen.1[9] The product also had an unanticipated outcome of reducing herpes 
simplex virus type 2 transmission by 51%.[10] However, enthusiasm for the success of a 
tenofovir-based microbicide was reduced by the subsequent VOICE clinical trial, when the study 
arm assessing daily dosage of a tenofovir gel was suspended because of ineffectiveness.[11] 
Adherence to microbicide regimens continues to present challenges in clinical trials, suggesting 
that the pro-ducts’ potential effectiveness would be limited. Adherence appears to be influenced 
by microbicide dimensions such as timing of use in relation to sexual activity and whether the 
product has lubricating qualities that increase sexual comfort and pleasure.[12-14] Another 
potential factor is whether a microbicide offers dual protection: Limited research has suggested 
that young women value contraceptive properties of microbicides.[15] However, little is known 
about whether these preferences vary over time or are influenced by relationship characteristics 
and contraceptive behaviors. 
Potential contraceptive microbicides, like other dual prevention methods, must be considered 
within the context of sexual relationships, because such relationships are associated with young 
women's utilization of contraceptive and disease prevention methods.[16] For example, male 
partners and relationship dynamics are associated with diaphragm,[17] condom[16, 18] and 
microbicide[19, 20] use. Individuals in longer term and closer relationships tend to use barrier 
methods less than individuals in casual relationships, because their perceived risk of STDs is 
lower and their use of hormonal contraceptives is greater.[7, 21] Additionally, sex partner 
communication and young women's relationship power are positively associated with 
contraceptive practices within relationships.[22, 23] These considerations suggest that sex 
partner and relationship-specific characteristics may be important as women evaluate 
microbicide acceptability. 
Using longitudinal data from a cohort of adolescent and young adult women, this study had three 
goals: to determine the importance of contraceptive ability relative to that of other microbicide 
dimensions; compare the acceptability of a hypothetical contraceptive microbicide with that of 
noncontraceptive ones; and examine associations between preferences for a hypothetical 
contraceptive microbicide and sexual relationship characteristics. 
Methods 
Our study uses data from a 10-year longitudinal investigation of young women's sexual health 
and sexual behaviors, initiated in 1999[24]; these data were collected between 2004 and 2008. 
The larger study recruited nonpregnant, English-speaking, young women attending three primary 
care clinics in Indianapolis. The clinics serve areas characterized by high rates of STDs and early 
childbearing, and low rates of HIV.[4, 25, 26] Sexual experience and activity were not 
enrollment criteria, and participants who became pregnant during the study were permitted to 
continue. Eligible patients were approached during their clinic visits and informed of the tasks 
involved in the longitudinal study (i.e., that they would be asked to keep daily diaries, collect 
specimens using vaginal swabs, undergo STD testing and participate in structured quarterly 
interviews). Most frequently, enrollment procedures were completed at separately scheduled 
appointments, approximately two weeks after initial consent. All study protocols were approved 
by the Indiana University School of Medicine's institutional review board; written informed 
consent was obtained from each participant and, for minor adolescents, from parents. 
Data were obtained through structured quarterly interviews that lasted approximately 25 minutes. 
As we were interested in longitudinal microbicide preferences, only participants who contributed 
two or more quarterly visits were included in the present study. On average, women in our 
sample contributed 8.2 quarterly visits (standard deviation, 3.7) across approximately four years. 
Although participants could list up to five sex partners in each interview, they generally (i.e., at 
85% of visits) reported only one partner; therefore, we included data only from the most recent 
partner. 
Measures 
Contraceptive microbicide preferences 
Participants were informed that microbicides are creams or jellies that may prevent, but not treat 
or cure, STDs and that microbicides were currently under development and not commercially 
available. Women were also told that microbicides work in a similar manner to spermicides 
(described as cream or jellies that have to be placed into the vagina every time sex occurs to kill 
sperm) and that to prevent STDs, they must be used every time a person has sex. Participants 
were asked to imagine that microbicides were available for the same cost as condoms.[27] Next, 
they were presented with scenarios describing nine hypothetical microbicides, each defined by a 
combination of four multilevel dimensions: contraceptive ability (“prevents pregnancy” or 
“doesn't prevent pregnancy”), STD prevention efficacy relative to that of condoms (“doesn't 
work as well as condoms,” “works almost as well as condoms” or “works as well as condoms”), 
timing of use (“one hour before sex,” “5–10 minutes before sex” or “5–10 minutes after sex”) 
and texture (“feels greasy” or “doesn't feel greasy”). For example, one scenario said, “This 
microbicide is used 5–10 minutes before sex, it feels greasy, it prevents STDs and pregnancy, 
and it works almost as well as condoms.” 
Given that two dimensions had three levels and two had two levels, assessment of all possible 
combinations of factors would have required administration of 36 questions, which would have 
been quite burdensome to respondents. To make the task more manageable for 
respondents,[28] we used SPSS 17 to derive a fractional factorial design that reduced the number 
of items to nine—six contraceptive microbicide scenarios and three noncontraceptive ones (box). 
The fractional factorial design also allows for examination of the main effects of each dimension. 
Scenarios were presented to participants in a different order at each quarterly visit to limit the 
possible influence of ordering effects. Participants were asked to rate their likelihood of using 
each hypothetical microbicide on a probability scale ranging from 0 (“I would never try this 
microbicide”) to 100 (“I would definitely try this microbicide”) in increments of 10. We then 
developed and evaluated two mean composite scores, contraceptive microbicide preferences 
(using the six contraceptive scenarios) and -noncontraceptive microbicide preferences (using the 
three noncontraceptive scenarios), to determine which scenarios were most preferred by 
participants. 
Use of contraceptives 
At each quarterly visit, participants were asked whether they had used each of the following 
contraceptive methods in the past 2–3 months: condom, spermicide, pill, injectable, patch, IUD, 
tubal ligation, emergency contraception, diaphragm, vaginal ring, withdrawal and rhythm. 
Reported use of any particular method led to a follow-up question asking if the participant was 
currently using that method. (The questionnaire did not include follow-up questions on 
emergency contraception, tubal ligation or withdrawal.) We used responses to these items to 
create variables indicating the number of contraceptives used in the recent past and the number 
currently used, as well as no use in the recent past and no current use. 
Commitment to avoiding pregnancy 
Participants were asked the extent to which they agreed with one statement: “I am very 
committed to not getting pregnant at this time in my life.” Responses were on a Likert-type scale 
ranging from 1 (“strongly disagree”) to 4 (“strongly agree”). 
Pregnancy desire 
Participants were asked how important it was to have sex with their partner because they were 
trying to get pregnant and because their partner wanted them to get pregnant. Responses were 
scored on a three-point scale (1=“not important”; 3=“important”). Through use of discrepancy 
analyses, perceived partner values were subtracted from participant values. Resulting scores 
were then recoded for ease of interpretation. Scores of −2 to −1 were recoded to signify that the 
participant desired pregnancy. Scores of 1 and 2 were recoded to denote that the partner desired 
pregnancy. Scores of 0 indicated that the participant and her partner agreed on pregnancy 
intention. We then used these data to develop two dichotomous items, one indicating that the 
couple agreed on avoiding pregnancy, the other that they agreed on seeking pregnancy. 
Sex partner communication 
This scale was an average composite score of three items, which asked the extent to which young 
women agreed that they felt comfortable speaking to their partner about sex, that it was easy to 
talk to their partner about using condoms or dental dams, and that it was easy to talk to their 
partner about using birth control (Cronbach's alpha, 0.81). All items were assessed on a four-
point Likert-type scale (1=“strongly disagree”; 4=“strongly agree”). 
Sexual agency 
To assess young women's perceptions of relationship power and control, we developed a scale by 
combining responses to three items: “It's easy for me to say no if I don't want to have sex,” “It is 
easy for him to take advantage of me” and “Sometimes things just get out of control with him.” 
Responses were on a four-point Likert-type scale (1=“strongly disagree”; 4=“strongly agree”). 
The last two items were recoded prior to inclusion in the scale to ensure that all items were in the 
same direction (Cronbach's alpha, 0.76). 
Sexual behavior 
We also examined five sexual behavior variables, each measured by one question: participants’ 
age at first sex, lifetime number of sex partners,2 number of partners in the past 2–3 months, 
number of episodes of sex in the past 2–3 months and condom use during last sex. 
Characteristics of nine hypothetical microbicides described to participants in a study of 
young women's microbicide preferences 
Timing of use Contraceptive 
ability 
Texture STD prevention efficacy compared 
with that of condoms 
5–10 minutes 
after sex 
No Greasy Not as good 
1 hour before sex No Not 
greasy 
Almost as good 
5–10 minutes 
before sex 
No Greasy As good 
1 hour before sex Yes Greasy Not as good 
5–10 minutes 
before sex 
Yes Not 
greasy 
Not as good 
5–10 minutes 
before sex 
Yes Greasy Almost as good 
1 hour before sex Yes Greasy As good 
5–10 minutes 
after sex 
Yes Greasy Almost as good 
5–10 minutes 
after sex 
Yes Not 
greasy 
As good 
 
Analyses 
The main variable of interest, contraceptive microbicide preferences, was evaluated through use 
of conjoint analysis, a regression-based technique that was originally developed in marketing 
research but has gained traction in assessing heath care preferences.[15, 29, 30]Conjoint analysis 
evaluates the acceptability of a product on the basis of specific features of that product. We 
conducted two types of conjoint analyses to examine longitudinal preferences for contraceptive 
microbicides in different ways. First, we employed full-profile, group conjoint analysis to 
calculate part-worth utility scores, which reflect relative preferences for each microbicide 
characteristic. These scores indicate, for the entire sample across all quarterly visits, the 
preference for each level of each microbicide dimension relative to the preference for all other 
dimensions and levels. For example, they indicate preferences for both a microbicide's ability to 
prevent pregnancy and its inability to prevent pregnancy relative to preferences for all other 
characteristics. 
Part-worth utility scores sum to 0 for each dimension; the more that respondents distinguished 
among levels, the wider the range of scores. For instance, if a contraceptive microbicide was 
strongly preferred relative to a noncontraceptive one, the contraceptive microbicide would have a 
high positive part-worth utility score, and the -noncontraceptive one would have an equally 
strong but negative part-worth utility score. For this study, we defined part-worth utility scores 
ranging from 0.0 to 3.4 (whether positive or negative) as denoting a low preference, 3.5–6.0 as 
signifying a moderate preference and 6.1 or more as indicating a strong preference. 
We then calculated importance scores, which reflect the degree to which each microbicide 
dimension influenced ratings of the nine scenarios. Importance scores were calculated by 
dividing the range of part-worth utility scores for a particular dimension by the sum of all part-
worth utility scores across all four dimensions. The sum of importance scores across dimensions 
always equals 100. 
Individual conjoint analyses were then conducted with contraceptive ability part-worth utility 
scores to evaluate each participant's preferences for -contraceptive -microbicides at each 
quarterly visit. As participants’ -interest in using contraceptive microbicides could be affected by 
a number of variables (e.g., relationship length), individual part-worth utility scores were lagged 
within participant and within sexual partnership at each quarterly visit. This enabled us to 
examine individual preferences for contraceptive microbicides while controlling for previous -
partner-specific behavior at all quarterly visits. Thus, our unit of analysis was quarterly visit, 
rather than participant. We also used our individual part-worth utility scores to explore if 
contraceptive microbicide preferences exceeded noncontraceptive microbicide preferences 
within our sample. 
Finally, we examined Pearson's product–moment correlations to investigate the relationship 
between contraceptive microbicide preferences and contraceptive behaviors, pregnancy desire 
and sexual relationship experiences. 
Results 
Participant Characteristics 
A total of 266 women aged 14–22 (mean, 17.3) in 2004 provided responses across 1,238 
quarterly visits (Table 1). Of these women, 89% were black, 7% were white, 3% were biracial, 
and the rest were Asian or Hispanic. On average, participants had first had vaginal sex at 14 
years of age and had had a total of six partners. In the past 2–3 months, young women had had an 
average of one sexual partner and had engaged in sex 15 times; 40% of those with sexual 
experience had used a condom during their last sexual encounter (not shown). 
Table 1. Selected characteristics of participants and their quarterly visits in a longitudinal 
study of young women's microbicide preferences, Indianapolis, 2004–2008 
Characteristic % or mean 
PARTICIPANTS (N=266) 
Demographic/sexual behavior   
Race/ethnicity (%)   
Black 89.0 
White 7.0 
Biracial 3.0 
Hispanic 0.5 
Asian 0.5 
Age in 2004 (range, 14–22) 17.3 (2.0) 
Age at first sex (range, 10–18)a 14.5 (1.5) 
Lifetime no. of partners (range, 0–>30) 6.4 (5.2) 
Recent no. of partners (range, 0–5)b 1.2 (0.5) 
No. of recent episodes of sex (range, 0–400)b 15.3 (24.6) 
Contraceptive/relationship   
No. of contraceptives used in the recent past (range, 0–6)b 1.6 (1.1) 
No. of contraceptives currently used (range, 0–4) 1.1 (0.9) 
Commitment to avoiding pregnancy (range, 1–4) 3.4 (0.8) 
Sexual partner communication (range, 1–4) 3.4 (0.6) 
Sexual agency (range, 1–4) 3.5 (0.5) 
QUARTERLY VISITS (N=1,238) 
Contraceptive/relationship (%)   
No recent past contraceptive useb 17.3 
No current contraceptive use 26.6 
Participant desires pregnancy 1.2 
Partner desires pregnancyc 9.7 
Couple agree on pregnancy intentionc 86.5d 
Couple agree on avoiding pregnancyc 81.5 
Couple agree on seeking pregnancyc 6.2 
 a Based on sexually experienced participants. 
b Refers to previous 2–3 months. 
c Based on women's -reports of their partners’ preferences. 
d Agreement on avoiding and seeking pregnancy do not add to total -because of missing values 
and rounding. 
Note: Unless otherwise noted, data are means (and standard deviations). 
 
On average, participants reported past use of two contraceptive methods and current use of one. 
Young women reported high levels of commitment to avoiding pregnancy, sexual partner 
communication and sexual agency (means, 3.4–3.5 on scales of 1–4). 
Participants reported no past contraceptive use during 17% of all quarterly visits and no current 
use during 27% of all quarterly visits. In 1% of visits, participants reported that they desired a 
pregnancy; in 10%, they reported that their partners did. However, they reported in 87% of all 
visits that they and their partners agreed on pregnancy intention; for the most part, they said that 
they agreed on avoiding pregnancy. 
Women reported using different contraceptive methods throughout the study (Table 2). The most 
widely used contraceptives in the past 2–3 months were condoms (reported in 58% of visits), 
withdrawal (28%) and injectables (26%). The least used were the diaphragm, the vaginal ring 
and tubal ligation (0–1%). The most widely used current methods were condoms (52%), 
injectables (25%) and rhythm (13%); the least used methods were the diaphragm, the vaginal 
ring and IUDs (0–1%). 
Table 2. Percentage of quarterly visits in which women reported recent or current use of 
specific contraceptive methods 
Method Recenta Current 
Condom 58.1 51.9 
Spermicide 2.6 2.1 
Pill 11.5 8.6 
Injectable 26.1 24.6 
Patch 8.9 7.4 
IUD 1.1 1.0 
Tubal ligation 0.8 na 
Emergency contraception 2.3 na 
Diaphragm 0.0 0.0 
Vaginal ring 0.7 0.5 
Withdrawal 27.5 na 
Rhythm 16.3 12.7 
 a Refers to previous 2–3 months. 
Note: na=not applicable because question was not asked. 
 
Conjoint Results 
At 6% of the 1,238 quarterly visits, participants gave the same rating to all nine scenarios. 
Because of the requirement of variability across scenarios, these visits were excluded, and the 
overall model was based on 1,167 lagged quarterly visits. 
Group 
The dimension that was most important in determining respondents’ ratings of microbicide 
acceptability was efficacy relative to that of condoms (importance score, 40.0); next was 
contraceptive ability (35.4), then timing of use (17.4) and finally texture (7.2). Within the 
efficacy dimension, participants indicated a strong preference for microbicides to be as 
efficacious as condoms (part-worth utility score, 8.2—Table 3), a moderate preference for 
microbicides to be almost as efficacious as condoms (3.8) and a very strong negative preference 
for them to be less efficacious than condoms (−11.9). Within the contraceptive ability dimension, 
participants endorsed a strong preference for contraceptive microbicides (8.9) and an equally 
strong negative preference for noncontraceptive ones (−8.9). In fact, the preference for 
contraceptive microbicides exceeded the preference for any other microbicide feature; similarly, 
the negative preference for noncontraceptive microbicides was stronger than any other negative 
preference except that for products that are less efficacious than condoms. With regard to timing 
of use, we found a moderate preference for microbicides that could be used 5–10 minutes after 
sex (4.3), a very slight preference for ones that could be used 5–10 minutes before sex (0.1) and 
a moderate negative preference for products that could be used one hour before sex (−4.4). As 
for texture, young women indicated a slight preference for nongreasy microbicides (1.8) over 
greasy ones (−1.8). 
Table 3. Part-worth utility scores from group conjoint analysis of relative preference for 
selected microbicide dimensions 
Dimension Score 
STD prevention efficacy compared   
with that of condoms   
As good 8.2 
Almost as good 3.8 
Not as good −11.9 
Contraceptive ability   
Yes 8.9 
No −8.9 
Timing of use   
5–10 minutes after sex 4.3 
5–10 minutes before sex 0.1 
1 hour before sex −4.4 
Texture   
Not greasy 1.8 
Greasy −1nnn8 
 Individual 
The scenarios involving contraceptive microbicides were rated more positively (mean part-worth 
-utility score, 58.2; standard deviation, 22.1) than those involving noncontraceptive microbicides 
(mean, 40.4; standard deviation, 21.8). At the item level, the most acceptable microbicide was 
one that had contraceptive ability, would be used 5–10 minutes after sex, would not feel greasy 
and would work as well as condoms; this hypothetical product received a mean score of 72.9 
(standard deviation, 29.1). The least acceptable microbicide was one that would not prevent 
pregnancy, would be used 5–10 minutes after sex, would feel greasy and would not work as well 
as condoms; this hypothetical product received a mean score of 33.2 (standard deviation, 25.0). 
Pearson Correlations 
The preference for a contraceptive microbicide was correlated with all measured characteristics 
reflecting women's contraceptive use and sexual relationships except past contraceptive use and 
partner's pregnancy desires (Table 4). It was positively correlated with participants’ reports of 
current contraceptive use, partner agreement about pregnancy intention, couples’ agreement to 
avoid pregnancy, commitment to avoiding pregnancy, partner communication about sex and 
sexual agency (coefficients, 0.07–0.18). It was negatively correlated with reports of no current 
contraceptive use, no past contraceptive use, desiring pregnancy and couples’ agreement to seek 
pregnancy (−0.08 to −0.14). 
Table 4. Coefficients from analyses assessing the correlation between selected 
characteristics of women and their preference for a contraceptive microbicide 
Characteristic Coefficient 
 Current contraceptive use 0.10b 
Past contraceptive used 0.04 
No current contraceptive use −0.14c 
No past contraceptive used −0.13c 
Desires pregnancy −0.08a 
Partner desires pregnancye −0.04 
Couple agree on pregnancy intentione 0.07a 
Couple agree on avoiding pregnancye 0.13c 
Couple agree on seeking pregnancye −0.13c 
Commitment to avoiding pregnancy 0.18c 
Sexual partner communication 0.10b 
Sexual agency 0.14c 
 a p<.05. 
b p<.01. 
c p<.001. 
d Refers to previous 2–3 months. 
E Based on women's reports of their partners’ preferences. 
 
Discussion 
Researchers have demonstrated a worldwide need for dual protection options to protect women 
against infection and unwanted conception.[6] Examination of the molecular structure of 
compounds with contraceptive and anti-HIV properties reveals the feasibility of incorporating 
dual compounds into one microbicide product.[5] Furthermore, knowing that one product can 
help prevent STDs and pregnancy might encourage women to use it properly (in clinical trials 
and in actual use), and if such a product were provided at a similar cost to other prevention 
methods, it may be especially valuable for young women with limited financial resources. 
Our results extend existing literature on microbicide preferences by documenting that over time, 
young women maintain a preference for microbicides with contraceptive abilities. Efficacy 
relative to that of condoms was the most important overall dimension associated with 
microbicide acceptability, followed closely by contraceptive ability. However, when the various 
levels of each microbicide dimension were evaluated, young women rated -contraceptive ability 
to be the most significant attribute of microbicides and a lower efficacy than that of condoms to 
be the least preferred characteristic. Moreover, the most preferred microbicide scenarios 
described hypothetical products that were contraceptive and efficacious, highlighting the 
importance of and need for more dual protection methods. 
The most preferred microbicide scenarios described hypothetical products that were 
contraceptive and efficacious [for STD prevention]. 
Our findings support previous research showing that young women value some microbicide 
dimensions and levels more than others.[13, 15, 31, 32] For example, texture and timing of use 
were reported to be the least significant microbicide dimensions. Still, participants clearly 
demonstrated preferences for nongreasy microbicides used 5–10 minutes after sex. Despite this 
finding, poorest adherence to microbicide regimens has been found for products intended to be 
used after sex,[12] suggesting that preferences and actual behavior regarding timing of use vary 
significantly.[12, 33] As microbicide clinical and safety trials continue, concurrent product 
acceptability research that incorporates multiple product dimension levels should be pursued, 
especially work aimed at clarifying these distinctions among adolescents and young adults.[13, 
15, 34] 
These data also suggest that contraceptive microbicides were important to women who were 
committed to pregnancy prevention and to those who were currently using contraceptives. The 
hypothetical contraceptive microbicides may have been attractive to these young women because 
they represented an alternative pregnancy prevention option. 
Young women who reported no current or past contraceptive use were relatively unlikely to 
prefer contraceptive microbicides. For some, this may reflect an ongoing unwillingness or 
inability to use preventive measures. For others, however, it may reflect a desire for pregnancy, 
as women in our sample were transitioning into their mid-20s, the age range in which the 
likelihood of intended pregnancy is highest.[35] Additional research should consider whether 
contraceptive microbicide acceptability varies across women's reproductive years on the basis of 
their childbearing desires. 
Some of our results are consistent with previous findings on the association between relationship 
dynamics and contraceptive decisions,[17, 20, 36-39] including a preference for dual methods of 
contraception.[40] We discovered that both partner communication and sexual agency were 
associated with a preference for contraceptive microbicides. Young women who communicated 
well with their partners may have been more comfortable than others in expressing their desire to 
delay pregnancy. Similarly, those reporting high levels of sexual agency may have felt more -
empowered within their relationship to take steps to prevent STDs and unwanted pregnancy. 
However, our findings run counter to work showing that women in relationships with less sexual 
power are more interested in preventing pregnancy.[22, 39, 41] Our results thus add to the 
literature by emphasizing that positive relationship dynamics and increased relationship power 
are also associated with a desire for contraceptive microbicides. This implies that although 
microbicides are commonly touted as a woman-initiated prevention method, the desire for and 
potential utilization of these methods may be linked to a variety of (often positive) facets of one's 
sexual relationship. 
Preferences for contraceptive microbicides were aligned with perceived partner agreement about 
pregnancy intention. They were positively correlated with couples’ agreement on avoiding a 
pregnancy and negatively correlated with couples’ wish to seek pregnancy. Thus, interest in 
having children and, especially, perceived partner agreement concerning childbearing are 
important issues as young women consider their preference for contraceptive microbicides and 
may have implications for health care providers’ contraceptive discussions with young women. 
Limitations and Future Research 
Several limitations to this study should be noted. First, the data were derived from a larger study 
of sexuality and sexual behaviors among young women. As a result, the variables of interest 
were constrained to those available in the larger study. Second, the generalizability of this study 
is limited by the demographic profile of the participants (e.g., primarily black), recruitment from 
community primary care clinics in Indianapolis and potential selection bias (i.e., participants 
were all women who agreed to engage in the demanding larger longitudinal study). Third, the 
partner agreement measure assessed young women's own pregnancy desire and their assessment 
of their partners’ pregnancy desire; participants may have overestimated or underestimated their 
partners’ intentions. However, young women's perceptions of their partners’ attitudes likely 
influence their sexual, contraceptive and disease prevention behaviors.[16-20] 
Future research would benefit from a more comprehensive assessment of associations between 
relationship characteristics and microbicide preferences (and contraceptive and STD prevention 
behaviors). Inclusion of additional relationship variables (e.g., relationship length, fidelity) 
would elucidate more explicit and nuanced ways by which relationships may influence 
contraceptive microbicide preferences. Mixed-methods research and studies involving sexual 
partners may also be helpful in providing insight into individual and relationship facets that 
contribute to microbicide acceptability. Although not directly evaluated in the present study, 
desire for contraceptive microbicides may shift across time as women's pregnancy and 
childbearing desires change.[15] Additional research is needed to determine how pregnancy 
intentions and ambivalence may influence contraceptive microbicide acceptability and utilization 
throughout the reproductive years. Studies that include more diverse samples are also needed to 
determine if preferences for contraceptive microbicides vary across groups. Furthermore, future 
research should assess microbicide acceptability within the context of recent prevention 
innovations and clinical trial outcomes. 
Conclusions 
Microbicides are unique in their potential to have both contraceptive and disease prevention 
properties, and young women indicate an interest in this type of product. Future research is 
needed to evaluate product specifications, relationship dynamics and pregnancy intentions 
associated with preference for an actual microbicide product. Upon development of 
contraceptive microbicides, it is essential that adolescent and young women be involved in 
clinical trials to examine the factors associated with acceptability and effectiveness. Widespread 
adoption of contraceptive microbicides could play an important role in reducing the enormous 
cost associated with unwanted pregnancy and STDs. 
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